Cargando…

1147. A study of high-dose influenza vaccination responses compared to standard-dose in lupus patients: an open- labeled, randomized controlled study

BACKGROUND: Annual influenza vaccination at standard dosing in the general population is suggested. However, there may be more suitable for lupus patients. OBJECTIVES: To assess the immune responses among lupus patients receiving high dose (HD) and standard (SD) quadrivalent inactivated influenza va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yingyounyong, Sasicha, Ngamjanyaporn, Pintip, Pisitkun, Prapaporn, Boonnak, Kobporn, Suangtamai, Thanitta, Thongpradit, Supranee, Rotjanapan, Porpon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679298/ http://dx.doi.org/10.1093/ofid/ofad500.988

Ejemplares similares

Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies
por: Laisuan, Wannada, et al.
Publicado: (2020)

2684. The Prospective Pilot Study of Infectious Complication Surveillance in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Cellular Response and Clinical Outcomes
por: Rotjanapan, Porpon, et al.
Publicado: (2019)

2655. A Prospective Study of Cytomegalovirus Infection in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Epidemiology, Associated Risk Factors, Pathogenesis, and Clinical Outcomes
por: Bushyakanist, Asalaysa, et al.
Publicado: (2019)

2222. A study of the role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatment: An open-labeled, randomized controlled trial
por: Munthananuchat, Paopat, et al.
Publicado: (2023)

Health related quality of life in anti interferon γ autoantibody associated immunodeficiency syndrome measured with EQ5D5L and SF36
por: Temsangsukmanee, Jirat, et al.
Publicado: (2023)

280. A cross-sectional pilot study on the relationship of gut microbiota pattern to immunogenicity of influenza vaccine in lupus patients
por: Kiewsanuan, Nathathai, et al.
Publicado: (2023)

Vaginal microbiota affects urinary tract infection risk in women with systemic lupus erythematosus: a pilot cross-sectional study from Thailand
por: Rotjanapan, Porpon, et al.
Publicado: (2021)

Performance of cytokine models in predicting SLE activity
por: Ruchakorn, Nopparat, et al.
Publicado: (2019)

The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients
por: Wangriatisak, Kittikorn, et al.
Publicado: (2021)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

CD4(+) T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLE
por: Wangriatisak, Kittikorn, et al.
Publicado: (2022)

A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants
por: Bruminhent, Jackrapong, et al.
Publicado: (2021)

Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population
por: Tangtanatakul, Pattarin, et al.
Publicado: (2020)

The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus
por: Thanadetsuntorn, Chokchai, et al.
Publicado: (2018)

Acute respiratory failure secondary to eosinophilic pneumonia following influenza vaccination in an elderly man with chronic obstructive pulmonary disease
por: Pornsuriyasak, Prapaporn, et al.
Publicado: (2014)

Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios
por: Ngamjanyaporn, Pintip, et al.
Publicado: (2022)

Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients
por: Seree-aphinan, Chutima, et al.
Publicado: (2023)

Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients
por: Chanprapaph, Kumutnart, et al.
Publicado: (2022)

Serum sickness-like reaction following an administration of the first dose of inactivated COVID19 vaccine
por: Chaijaras, Sasipim, et al.
Publicado: (2021)

Absence of cutaneous involvement in disseminated Talaromyces marneffei infection in an AIDS patient: a case report and literature review
por: Pongpech, Nisha, et al.
Publicado: (2019)

Lupus-like Disease in FcγRIIB(−/−) Mice Induces Osteopenia
por: Visitchanakun, Peerapat, et al.
Publicado: (2019)

Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study
por: Tanpaibule, Tananun, et al.
Publicado: (2020)

Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study
por: Sodsri, Tulaton, et al.
Publicado: (2023)

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL
por: Maria Ribera, Josep, et al.
Publicado: (2023)

1147. Improving Accessibility and Antibiotic Prescribing with an Enhanced Digital Antibiogram
por: Yarahuan, Julia K, et al.
Publicado: (2019)

1147. Pseudo-Outbreak of Clostridium paraputrificum Related to Anaerobic Tent Contamination
por: Mitchell, Kaitlin, et al.
Publicado: (2018)

1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19
por: Asai, Yusuke, et al.
Publicado: (2022)

cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus
por: Kumpunya, Sarinya, et al.
Publicado: (2022)

A case report of intravenous posaconazole in hepatic and renal impairment patient with invasive Aspergillus terreus infection: safety and role of therapeutic drug monitoring
por: Dilokpattanamongkol, Pitchaya, et al.
Publicado: (2017)

Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study
por: Kittivisuit, Sirinthip, et al.
Publicado: (2021)

Biomarkers for Refractory Lupus Nephritis: A Microarray Study of Kidney Tissue
por: Benjachat, Thitima, et al.
Publicado: (2015)

1147 Factors Associated with Spontaneous Resolution of HCV Infection in Untreated Individuals, Philadelphia
por: Kuncio, Danica, et al.
Publicado: (2014)

Cutaneous and Extracutaneous Manifestations of Behçet’s Disease Linked to Its Disease Activity and Prognosis
por: Limtong, Preeyachat, et al.
Publicado: (2020)

Respiratory Virus Vaccines
por: Broadbent, Andrew J., et al.
Publicado: (2015)

1147 Laboratory evidence of COVID-19 infection in gravidas in the first 6 months of the pandemic
por: Sutton, Desmond, et al.
Publicado: (2021)

Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study
por: Zhong, Nanshan, et al.
Publicado: (2013)

Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb(-/-) lupus model
por: Sakunrangsit, Nithidol, et al.
Publicado: (2021)

Demographic, clinical and comorbidity data in a large sample of 1147 patients with migraine in Mexico City
por: Téllez–Zenteno, J. F., et al.
Publicado: (2005)

1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation
por: Thim-uam, Arthid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d1e49vrurv60e5b3nt4qbd0flh